Tentative Program

4 May 2012 (Friday)

10:00 - 22:00 On-Site Registration
 13:30-19:00 Venue: Hall One
Spinal Cord Injury Trials: Industry Perspective
Moderators: Mahendra Rao & Wise Young
13:30-19:00 Venue: Hall Two
13:00 - 13:30 Human Neural Stem Cell - Karl Johe, NeuralStem. US 13:00-15:30 Neurorestoratological Youth Forum
- Geoffrey Raisman
- Paul R. Sanberg
13:30 - 14:00 Gene-modified Mesenchymal Stem Cells for Neural Regeneration: Translating Clinical Experience in Chronic Stroke to Spinal Cord Injury -  Casey Case, SanBio, US
14:00 - 14:30 Cethrin treatment for acute spinal cord injury: clinical trial update - Lisa McKerracher, Bioaxone Biosciences, USA
14:30 - 15:00 Neuroprotectant for treating spinal cord injury, Nogo receptor and beyond - Daniel Lee, Roche Pharmaceutical Research & Early Development Center
15:00 - 15:10 Tea Break 15:30-17:30 Round-table Meeting: neurorestoratology of stroke
15:10 - 15:40 Umbilical Cord Blood Mononuclear Cell Therapy of SCI and Stroke - Wise Young, Stemcyte, US
15:40 - 16:10 Overview on Celgene Cellular Therapeutics - Bob Hariri, Celgene Cellular Therapeutics, US
16:10 - 16:40 Spinal Cord Injury and cell based therapy - Mahendra Rao, NIH 17:30-19:00 Pain Forum: Traditions and Advances
- Ling Wei
- Baoliang Geng
- Lin Chen
16:40 - 17:00 Discussion
17:00 - 19:00 Roundtable Meeting: advances on neurorestoratology of spinal cord injury
19:00-21:00 Dinner

5 May 2012 (Saturday)

  Topic: Opening Ceremony & Keynote Presentation
Venue: Hall One
08:00 - 08:20 Opening Ceremony & Welcome Remark
Xijing He
Ziad AL-Zoubi
Hari Sharker Sharma  
08:20 - 08:50 Group Photo
08:50 - 12:10
Core Presentation
08:50 - 09:20  Challenges in Neurorestoratology - Geoffrey Raisman
09:20 - 09:50  Developing history of Neurorestoratology - Hongyun Huang
09:50 - 10:20  Progress of cell therapies in Neurorestoratology - Paul R. Sanberg
10:20 - 10:40  Tea Break
10:40 - 11:10  Pharmacotherapy Progress in Neurorestoratology - Hari Sharker Sharma
11:10 - 11:40  Neurorestoration of spinal cord injury by electrical stimulation - Reggie Edgerton
11:40 - 12:10  Progress on Spinal Cord Injury in Neurorestoratology - Wise Young
13:30-17:30 Venue: Hall One

Endogenous and Exogenous Repair Mechanisms for Regenerative Medicine
Moderators: Kwok-fai So & Pei Duanqing

Venue: Hall Two
13:30 - 14:00 Functional Significance of adult neural stem cell - Kwok-fai So, the University of Hong Kong 13:30-16:00  General Neurorestoratology

• CNS Injury & repair. Role of nanomedicine, Stem Cells, Antibodies and other therapeutic agents (Hari S. Sharma,Sweden)

• Plasticity of motor skill learning after brain lesions: mechanisms (Leonardo G. Cohen,USA)

• Post-Genome Technologies in Neurorestoratology: from Mapping and Profiling of Stem Cell Proteome to the Development of Personalized Cell Preparations for Regenerative Therapy of Neural Disorders (Andrey S.Bryukhovetskiy, Russia)

• The crosstalk between vascular and degenerative mechanism in neurocognitive disorders. Is there a place for endogenous neurogenesis? (Dafin F. Muresanu,Romania)

• Why is Cognitive Neuro-rehabilitation important and what can we do to improve it? (Dajue Wang,UK)

• Evaluation of stem cell transplantation for brain disorders (Nanbert Zhong,China)

• Nanomedicine and Central Nervous System: the application, the perspectives and the future (Giovanni Tosi,Italy)

• New data on restoration processes in traumatic brain injury, including the discovery of a new CSF hormone made by choroid plexus (Conrad Johanson,USA)

• Reconstruction of spinal cord function (Jianjun Li,China)
14:00 - 14:20 Clinical Trial of Umbilical Cord Blood Cell for Spinal Cord Injury - Gilberto Leung, University of Hong Kong
14:20 - 14:40 Umbilical Cord Blood Cell for Spinal Cord Injury: From Laboratory to Operation Theatre - Kent Tsang, Chinese University of Hong Kong
14:40 - 15:00 Surgical Aspect of Umbilical Cord Blood Cell Transplant to Spinal Cord – David Sun, Chinese University of Hong Kong
15:00 - 15:20 A neonatal mouse SCI model for testing human stem cells including high throughput functional imaging of synaptic condition - Joel Glover, The Norwegian Center for Stem Cell Research, Norway
15:20 - 15:30 Tea Break
15:30 - 16:00 Stereotaxic implantation of Olfactory ensheathing cell (OECs) for stroke patients - Woei-Cherng Shyu, China Medical University Hospital, Taiwan
16:00 - 16:30 Muse cells, a novel type of adult human pluripotent stem cells that reside in mesenchymal tissues: their great possibility for regenerative medicine - Mari Dezawa, Tohoku University, Japan 16:00-18:00  Geriatric Neurorestoratology

• Multiple cell transplantations of stroke patients (Hongyun Huang,China)

• Clinical consequences based on the laterality in Parkinson's disease (Peter Reiderer, Germany)

• Intracerebral implantation of Stem Cells Promotes the Regeneration of Corticospinal Tracts in Stroke Patients (Shinn-zong Lin,Taiwan,China)

• Neurorestoration strategies in Parkinsons Disease (Barry Hoffer,USA)
16:30 - 17:00 Reprogramming the somatic cell fate to pluripotency for regenerative medicine - Duanqing Pei, Guangzhou Institute of Biomedicine & Health, CAS, China
17:00 -17:30 Discussion
17:30-19:00 Hereditary Neurorestoratology

• Clinical results of autologous bone marrow derived adult stem cell transplantation in muscular dystrophy (Alok Sharma,India)

• Myogenic cell transplantation for Duchenne muscular dystrophy patients (Daniel Skuk,Canada)
18:00-19:00  Pediatric Neurorestoratology

• Pathways to Protection from Pediatric Anesthetics (William Slikker,USA)

• Neural precursor cell transplantation in the treatment of central visual impairment in children (Zuoluan,China)

• Integrated Regenerative Therapy Program (IRTP) for management of Autism and other disabilities(Yehia Yousif, Saudi Arabia)
19:00 - 21:00 Welcome Dinner

6 May, 2012 (Sunday)

  Venue: Hall One
  Venue: Hall Two
08:00 - 12:00  Traumatic Neurorestoratology

• Long-term follow-up observation on patients with spinal cord injury by Cell therapy (Xijing He,China)

• Long-term follow up results for patients with spinal cord injury by cell transplantation (Ziad Al-Zoubi,Jordan)

• Clinical Observation of Cell Transplantation in patients with SCI (Tiansheng Sun,China)

• Cell Transplantation in the Treatment of SCI (Shiqing Feng,China)

• Requirements for Interventions to prove Added Value to Neurological Recovery following Traumatic Spinal Cord Injuries (Wagih S El Masri,UK)

• Morbidity Aspects in Spinal Cord Injury with Insights into the Transplantation of Stem Cells in the Injured Cord (Ali Otom,Jordan)

• Electromyography monitoring for complete and incomplete transections of the spinal cord in humans who received a cell therapy combined with LASERPONCTURE® or LASERPONCTURE® only. Methodology, analysis, and results (Albert Bohbot,France)

• Fisical Therapy in stem cell implanted patients with spinal cord injury (María Teresita Moviglia Brandolino,Agentina)

• Four essential aspects to procure the the recovery of chronic complete Spinal Cord injured patients(Gustavo Moviglia, Argentina)

• Mobilization of bone marrow progenitor cells as novel marker of regenerative potential in traumatic brain injury (Elena Rem Chernykh,Russia)

• Olfactory bulb ensheathing glia transplants activate a repair-specific genetic program in neurons after spinal cord injury (Almudena Ramón Cueto,Spain)

• Olfactory Mucosa Transplantation for Spinal Cord Injury-Clinical Trial and Experimental Study (Koichi Iwatsuki,Japan)

• Safety of granulocyte-colony stimulating factor (G-CSF) administration in spinal cord injury patients (Hooshang Sabri,Iran)

• Clinical Cell Therapy in Spinal Cord Injury (Ming Lu,China)
08:00 - 09:00  Psychiatric Neurorestoratology
09:00 - 10:00  Pain Neurorestoratology

• Neurorestorative therapy for pain(Lin Chen,China)
10:00 - 11:00  Neuromodulation

• Neuromodulation improves Seizures and prognosis (Guoming Luan,China)

• Deep Brain Stimulation and neurogenesis, and in addiiton DBS and neuroprotection in Stroke models and Huntington Disease (Harry Steinbusch,Holland)

• Lumbar Spinal Cord Network processing capabilities: Spinal Cord Brain and features of motor control after spinal cord njury (Milan Dimitrijevic, Yugoslavia)

• Restored motor control after spinal cord injury(Arthur M. Sherwood,USA)
11:00 - 12:00  Tissue engineering and Bioengineering

• Nanotechniques for Neurorestoration (Russell J Andrews,USA)

• Tissue engineering technology for Neurorestoratology (Qunyuan Xu,China)

Venue: Hall One
  Venue: Hall Two
13:30-15:40  Surgical treatment of spinal column and spinal cord injury

• (Almudena Ramon Cueto)

• (Lichi Iwatsuki)

• (Hooshang Sabri

• (Ming Lu, China)

• (Shaocheng Zhang,China)
13:30 - 14:30  Neurorestorative Pharmacotherapy

• Bromocriptine prevents spinal motor neurons in vitro and in vivo (Yasuo Iwasaki,Japan)

• Protein kinases as therapeutic targets for central nervous system (Stephen Skaper,Italy)
14:30 - 15:30  Neural Prosthesis
15:30 - 17:00 Basic Research of Neurorestoratology & Others

• Neuroprotection by electroacupuncture against glutamate excitotoxicity-induced RGC death after optic nerve transection in adult rats (Siwei You,China)

• Regulated Delivery of GDNF Gene Using Bone Marrow-Derived Stem Cells Transduced With a Lentiviral Vector into Mouse Brain (Weiming Duan,China)

• Repair rat spinal roots by transplantation of olfactory ensheathing cells (Ying Li,UK)

• Directionality and bipolarity of olfactory ensheathing cells on electrospun nanofibres’ (Daqing Li,UK)

• Mechanisms underlying protective effects of neural stem cells against traumatic axonal injury (Ping Wu,USA)

• Neural potential of human cord blood and umbilical cord cells: a successful translation (Barbara Lukomska,Poland)

• Wharton jelly - natural scaffold and the rich source of mesenchymal stem cells (Anna Sarnowska,Poland)

• Neuronal spike sorting based on radial basis function neural networks (Alireza Khoshnevisan, Iran
15:40-17:00 Pediatric Neurorestoratology

Willianm Slikker, USA)

Zuo Luan, China

Yehia Yousif, Saudi Arabia)
17:00-1800   Closing Ceremony